🇺🇸 FDA
Pipeline program

ARO-APOC3 PFS, ARO-APOC3, 0.9% Normal Saline for injection

AROAPOC3-3001

Phase 3 small_molecule active

Quick answer

ARO-APOC3 PFS, ARO-APOC3, 0.9% Normal Saline for injection for Familial Chylomicronemia Syndrome (FCS) is a Phase 3 program (small_molecule) at Arrowhead Pharmaceuticals Ireland Limited with 1 ClinicalTrials.gov record(s).

Program details

Company
Arrowhead Pharmaceuticals Ireland Limited
Indication
Familial Chylomicronemia Syndrome (FCS)
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials